• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Teladoc Health Inc. (Amendment)

    2/10/23 10:30:23 AM ET
    $TDOC
    Medical/Nursing Services
    Health Care
    Get the next $TDOC alert in real time by email
    SC 13G/A 1 brhc10047843_sc13ga.htm SC 13G/A

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    SCHEDULE 13G
    Under the Securities Exchange Act of 1934
    (Amendment No. 1)*

    Teladoc Health, Inc.

    (Name of Issuer)

    Common Stock, par value $0.001 per share

    (Title of Class of Securities)

    87918A105

    (CUSIP Number)

    December 31, 2022

    (Date of Event Which Requires Filing of this Statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒
    Rule 13d-1(b)

    ☐
    Rule 13d-1(c)

    ☐
    Rule 13d-1(d)

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).



    CUSIP No.

    1
    NAMES OF REPORTING PERSONS
     
     
    Nikko Asset Management Americas, Inc.
     
     
     
     
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
    (a)☐
       
    (b)☐
     
     
    3
    SEC USE ONLY
     
     

     
     
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
     
    USA
     
     
     
     
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
     
    0
     
     
     
     
    6
    SHARED VOTING POWER
     
     
    5,250,685
     
     
     
     
    7
    SOLE DISPOSITIVE POWER
     
     
    0
     
     
     
     
    8
    SHARED DISPOSITIVE POWER
     
     
    8,125,231
     
     
     
     
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
     
    8,125,231
     
     
     
     
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
     
    ☐
     
     
     
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
     
    5.01%
     
     
     
     
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
     
    IA
     
     
     
     


    Item 1.

     
    (a)
    Name of Issuer
         
       
    Teladoc Health, Inc.
         
     
    (b)
    Address of Issuer’s Principal Executive Offices
         
       
    2 Manhattanville Road, Suite 203, Purchase, NY 10577

    Item 2.

     
    (a)
    Name of Person Filing
         
       
    Nikko Asset Management Americas, Inc.
         
     
    (b)
    Address of Principal Business Office or, if none, Residence
         
       
    605 Third Avenue, 38th Floor, New York, NY 10158
         
     
    (c)
    Citizenship
         
        USA
         
     
    (d)
    Title of Class of Securities
         
       
    Common Stock, par value $0.001 per share
         
     
    (e)
    CUSIP Number
         
       
    87918A105


    Item 3.
    If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     
    (a)
    ☐
    Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
           
     
    (b)
    ☐
    Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
           
     
    (c)
    ☐
    Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
           
     
    (d)
    ☐
    Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).
           
     
    (e)
    ☒
    An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
           
     
    (f)
    ☐
    An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
           
     
    (g)
    ☐
    A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
           
     
    (h)
    ☐
    A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
           
     
    (i)
    ☐
    A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
           
     
    (j)
    ☐
    A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J).
           
     
    (k)
    ☐
    A group, in accordance with § 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:


    Item 4.
    Ownership.

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

     
    (a)
    Amount beneficially owned:
         
       
    8,125,231
           
     
    (b)
    Percent of class:
         
       
    5.01%
           
     
    (c)
    Number of shares as to which the person has:
           
       
    (i)
    Sole power to vote or to direct the vote:
           
         
    0
           
       
    (ii)
    Shared power to vote or to direct the vote:
           
         
    5,250,685
           
       
    (iii)
    Sole power to dispose or to direct the disposition of:
           
          0
           
       
    (iv)
    Shared power to dispose or to direct the disposition of:
           
         
    8,125,231
           

    Item 5.
    Ownership of Five Percent or Less of a Class

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☐.

    Item 6.
    Ownership of More than Five Percent on Behalf of Another Person.

    See Exhibit A.

    Item 7.
    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company

    See Exhibit A.

    Item 8.
    Identification and Classification of Members of the Group

    Not Applicable.

    Item 9.
    Notice of Dissolution of Group

    Not Applicable.


    Item 10.
    Certification

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     
    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date: February 8, 2023
    By:
    /s/ Gary L. Beckham

     
    Name: Gary L. Beckham

     
    Title: Chief Compliance Officer

    Attention:
    Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001)


    Exhibit A

    Pursuant to the instructions in Items 6 and 7 of Schedule 13G, the security being reported on by Nikko Asset Management Americas, Inc., as subsidiary to the parent holding companies listed below, are owned, or may be deemed to be beneficially owned, by its parent holding companies.


    1)
    Sumitomo Mitsui Trust Holdings Inc.

    o
    A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);

    o
    A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J).


    2)
    Nikko Asset Management Co., Ltd.

    o
    An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

    o
    A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J).



    Get the next $TDOC alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TDOC

    DatePrice TargetRatingAnalyst
    7/25/2025$10.00Neutral
    Mizuho
    11/15/2024$14.00Buy
    Goldman
    9/17/2024$8.00 → $10.00Hold
    Jefferies
    2/29/2024$22.00Overweight
    Cantor Fitzgerald
    2/26/2024$17.00Market Perform
    Leerink Partners
    1/17/2024$33.00 → $22.00Buy → Neutral
    DA Davidson
    1/3/2024$26.00Overweight
    Barclays
    4/12/2023$25.00Equal-Weight
    Stephens
    More analyst ratings

    $TDOC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Teladoc Health Acquires Telecare, Expanding Access to Specialist and Allied Health Care for Australians in Public and Private Health

    MELBOURNE, Australia, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE:TDOC), the global leader in virtual care, today announced it has acquired Telecare, an innovative, Australian tech-enabled provider of specialist and allied health care via virtual delivery. Telecare operates Australia's leading virtual care clinic and provides software solutions to the healthcare sector. With over 300 virtual specialists in over 30 specialties, supporting both GP-referred appointments as well as providing virtual care services to public hospitals across Australia, Telecare helps reduce patient wait times and increases access to speciality care in underserved areas. Teladoc Health is the global

    8/14/25 5:00:10 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    Teladoc Health Reports Second Quarter 2025 Results

    NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended June 30, 2025 ("Second Quarter 2025"). Unless otherwise noted, percentage and other changes are relative to the three months ended June 30, 2024 ("Second Quarter 2024"). Highlights Second Quarter 2025 revenue of $631.9 million, down 2% year-over-yearSecond Quarter 2025 net loss of $32.7 million, or $0.19 per shareSecond Quarter 2025 adjusted EBITDA of $69.3 million, down 23% year-over-yearIntegrated Care segment revenue of $391.5 million, up 4% year-over-year, and adjusted EBITDA margin of 14.7%BetterHelp segment rev

    7/29/25 4:05:02 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    Wingspan Raises $24M Series B to Scale Embedded Contractor Management and Capture $1.4T Market

    Series B led by Touring Capital will propel Wingspan's mission to make flexible work effortless; launch of Wingspan Embed brings comprehensive contractor management to HR platforms NEW YORK, July 29, 2025 /PRNewswire/ -- Wingspan, the first modern payroll platform purpose-built for contractor management, announced that it has raised $24 million in Series B funding led by Touring Capital, bringing its total capital raised to $54 million. Existing investors Andreessen Horowitz, Long Journey Ventures, Distributed Ventures, Company Ventures, and 186 Ventures also participated. Wi

    7/29/25 9:00:00 AM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    $TDOC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Evans Jason Eric converted options into 1,016 shares, increasing direct ownership by 17% to 7,113 units (SEC Form 4)

    4 - Teladoc Health, Inc. (0001477449) (Issuer)

    6/23/25 4:11:27 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    CHIEF EXECUTIVE OFFICER Divita Charles Iii converted options into 156,641 shares (SEC Form 4)

    4 - Teladoc Health, Inc. (0001477449) (Issuer)

    6/11/25 4:19:12 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    President of BetterHelp Rodrigues Fernando M. converted options into 6,532 shares and sold $45,018 worth of shares (6,532 units at $6.89) (SEC Form 4)

    4 - Teladoc Health, Inc. (0001477449) (Issuer)

    6/3/25 5:37:24 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    $TDOC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Mckinley Thomas bought $30,756 worth of shares (4,000 units at $7.69), increasing direct ownership by 11% to 39,077 units (SEC Form 4)

    4 - Teladoc Health, Inc. (0001477449) (Issuer)

    9/13/24 5:14:02 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    Director Smith Mark Douglas bought $28,312 worth of shares (4,000 units at $7.08), increasing direct ownership by 92% to 8,355 units (SEC Form 4)

    4 - Teladoc Health, Inc. (0001477449) (Issuer)

    8/19/24 4:10:41 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    Director Mckinley Thomas bought $81,746 worth of shares (11,000 units at $7.43), increasing direct ownership by 46% to 35,077 units (SEC Form 4)

    4 - Teladoc Health, Inc. (0001477449) (Issuer)

    8/8/24 5:49:44 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    $TDOC
    SEC Filings

    View All

    SEC Form 10-Q filed by Teladoc Health Inc.

    10-Q - Teladoc Health, Inc. (0001477449) (Filer)

    7/30/25 12:52:34 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    Teladoc Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Teladoc Health, Inc. (0001477449) (Filer)

    7/29/25 4:12:16 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Teladoc Health Inc.

    SCHEDULE 13G/A - Teladoc Health, Inc. (0001477449) (Subject)

    7/29/25 2:40:16 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    $TDOC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Mizuho initiated coverage on Teladoc with a new price target

    Mizuho initiated coverage of Teladoc with a rating of Neutral and set a new price target of $10.00

    7/25/25 9:07:34 AM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    Goldman initiated coverage on Teladoc with a new price target

    Goldman initiated coverage of Teladoc with a rating of Buy and set a new price target of $14.00

    11/15/24 8:22:14 AM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    Jefferies reiterated coverage on Teladoc with a new price target

    Jefferies reiterated coverage of Teladoc with a rating of Hold and set a new price target of $10.00 from $8.00 previously

    9/17/24 8:21:59 AM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    $TDOC
    Leadership Updates

    Live Leadership Updates

    View All

    $TDOC
    Financials

    Live finance-specific insights

    View All

    $TDOC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Teladoc Health Board of Directors Announces Leadership Transition

    Jason Gorevic to depart the company, effective immediatelyCFO Mala Murthy appointed acting chief executiveTeladoc Health reaffirms guidance PURCHASE, NY, April 05, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today announced that Jason Gorevic is departing the company, effective immediately. The Board of Directors has appointed Mala Murthy acting Chief Executive Officer while it searches for Mr. Gorevic's permanent successor. Ms. Murthy is a seasoned industry leader who has served as the Company's Chief Financial Officer since 2019, and she will continue serving in this role during this transition period. The Board has ret

    4/5/24 6:30:18 AM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    Teladoc Health Appoints Leading Healthcare and Hospitals Executive Eric Evans to Board of Directors

    PURCHASE, NY, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today appointed Eric Evans to the company's board of directors. Mr. Evans, currently chief executive officer and director of Brentwood, TN-based Surgery Partners, Inc. (NASDAQ:SGRY), is a recognized healthcare and hospital executive with significant experience leading complex organizations operating at the intersection of care and technology. Mr. Evans joins the board following the retirement of Senator William Frist, M.D. earlier this year, and will serve on the board's compensation committee. David B. Snow, Jr., non-executive Chairman of the company's board,

    9/20/23 8:05:00 AM ET
    $SGRY
    $TDOC
    Hospital/Nursing Management
    Health Care
    Medical/Nursing Services

    Gabriela Perez Joins Big Health as Chief Commercial Officer

    After spending two decades successfully scaling multiple healthcare technology companies, Perez joins Big Health to accelerate the commercial coverage and reimbursement for digital therapeutics Big Health, a digital therapeutics company dedicated to helping millions back to good mental health, today announced the appointment of Gabriela Perez as Chief Commercial Officer. In her new role, Perez will oversee Big Health's global commercial growth and strategy, including sales, client management, strategic partnerships, and new markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220203005297/en/Big Health Chief Commercial Office

    2/3/22 8:00:00 AM ET
    $LH
    $TDOC
    Medical Specialities
    Health Care
    Medical/Nursing Services

    Teladoc Health Acquires Telecare, Expanding Access to Specialist and Allied Health Care for Australians in Public and Private Health

    MELBOURNE, Australia, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE:TDOC), the global leader in virtual care, today announced it has acquired Telecare, an innovative, Australian tech-enabled provider of specialist and allied health care via virtual delivery. Telecare operates Australia's leading virtual care clinic and provides software solutions to the healthcare sector. With over 300 virtual specialists in over 30 specialties, supporting both GP-referred appointments as well as providing virtual care services to public hospitals across Australia, Telecare helps reduce patient wait times and increases access to speciality care in underserved areas. Teladoc Health is the global

    8/14/25 5:00:10 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    Teladoc Health Reports Second Quarter 2025 Results

    NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended June 30, 2025 ("Second Quarter 2025"). Unless otherwise noted, percentage and other changes are relative to the three months ended June 30, 2024 ("Second Quarter 2024"). Highlights Second Quarter 2025 revenue of $631.9 million, down 2% year-over-yearSecond Quarter 2025 net loss of $32.7 million, or $0.19 per shareSecond Quarter 2025 adjusted EBITDA of $69.3 million, down 23% year-over-yearIntegrated Care segment revenue of $391.5 million, up 4% year-over-year, and adjusted EBITDA margin of 14.7%BetterHelp segment rev

    7/29/25 4:05:02 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    Teladoc Health to Announce Second Quarter 2025 Financial Results

    NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE:TDOC), the global leader in virtual care, announced that it will release second quarter 2025 results on Tuesday, July 29, 2025, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. ET on the same day. Conference Call DetailsThe conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 606269. For international participants, please visit the following link for global dial-in numbers: https://www.netroadshow.com/conferencing/global-numbers?confId=85796. A live audio webcast will also be available online at https://

    7/16/25 4:30:58 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G filed by Teladoc Health Inc.

    SC 13G - Teladoc Health, Inc. (0001477449) (Subject)

    9/5/24 4:36:22 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by Teladoc Health Inc.

    SC 13G/A - Teladoc Health, Inc. (0001477449) (Subject)

    7/8/24 4:32:41 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G/A filed by Teladoc Health Inc. (Amendment)

    SC 13G/A - Teladoc Health, Inc. (0001477449) (Subject)

    2/13/24 5:16:08 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care